Illumina Stock Debt To Equity

ILMN Stock

USD 144.36 1.41 0.99%

Illumina fundamentals help investors to digest information that contributes to Illumina's financial success or failures. It also enables traders to predict the movement of Illumina Stock. The fundamental analysis module provides a way to measure Illumina's intrinsic value by examining its available economic and financial indicators, including the cash flow records, the balance sheet account changes, the income statement patterns, and various microeconomic indicators and financial ratios related to Illumina stock.

		Last Reported	Projected for Next Year
	Debt To Equity	0.26	0.30

As of the 28th of November 2024, Debt To Equity is likely to grow to 0.30.

This module does not cover all equities due to inconsistencies in global equity categorizations. Continue to Equity Screeners to view more equity screening tools.

Illumina Company Debt To Equity Analysis

Illumina's Debt to Equity is calculated by dividing the Total Debt of a company by its Equity. If the debt exceeds equity of a company, then the creditors have more stakes in a firm than the stockholders. In other words, Debt to Equity ratio provides analysts with insights about composition of both equity and debt, and its influence on the valuation of the company.

D/E

Total Debt

Total Equity

More About Debt To Equity | All Equity Analysis

Current Illumina Debt To Equity

0.38 %

Most of Illumina's fundamental indicators, such as Debt To Equity, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Illumina is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.

Illumina Debt To Equity Driver Correlations

Understanding the fundamental principles of building solid financial models for Illumina is extremely important. It helps to project a fair market value of Illumina Stock properly, considering its historical fundamentals such as Debt To Equity. Since Illumina's main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Illumina's historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Illumina's interrelated accounts and indicators.

	Total Assets	Total Stockholder Equity	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Current Deferred Revenue	Long Term Debt	Property Plant Equipment	Good Will	Treasury Stock	Net Tangible Assets	Capital Surpluse	Long Term Debt Total	Long Term Investments	Short Long Term Debt	Net Invested Capital	Net Working Capital	Capital Stock	Cash And Equivalents
Total Assets		0.98	0.71	0.51	0.98	0.91	-0.21	0.95	0.52	0.35	0.86	0.5	0.93	0.73	0.94	0.88	-0.91	0.54	0.86	0.78	0.79	0.81	0.95	-0.4	-0.37	-0.15
Total Stockholder Equity	0.98		0.64	0.6	0.95	0.85	-0.2	0.88	0.49	0.26	0.81	0.45	0.87	0.71	0.93	0.92	-0.88	0.45	0.81	0.76	0.77	0.77	0.96	-0.33	-0.31	-0.28
Net Debt	0.71	0.64		-0.11	0.72	0.65	-0.41	0.78	0.05	0.41	0.87	0.3	0.69	0.56	0.61	0.7	-0.49	0.26	0.82	0.68	0.33	0.8	0.71	-0.8	-0.49	0.09
Retained Earnings	0.51	0.6	-0.11		0.48	0.36	0.46	0.32	0.73	0.23	0.03	0.38	0.39	0.35	0.58	0.44	-0.62	0.17	0.05	0.17	0.62	0.12	0.48	0.44	0.33	-0.57
Accounts Payable	0.98	0.95	0.72	0.48		0.93	-0.18	0.96	0.54	0.4	0.83	0.55	0.96	0.75	0.95	0.83	-0.92	0.55	0.84	0.77	0.79	0.77	0.89	-0.43	-0.38	-0.09
Net Receivables	0.91	0.85	0.65	0.36	0.93		-0.11	0.95	0.59	0.33	0.78	0.6	0.99	0.69	0.91	0.65	-0.91	0.74	0.85	0.72	0.8	0.79	0.75	-0.31	-0.57	0.15
Short Term Investments	-0.21	-0.2	-0.41	0.46	-0.18	-0.11		-0.21	0.64	0.34	-0.62	0.31	-0.12	-0.16	-0.05	-0.44	-0.06	0.08	-0.53	-0.53	0.16	-0.26	-0.34	0.74	0.4	-0.09
Total Liab	0.95	0.88	0.78	0.32	0.96	0.95	-0.21		0.54	0.5	0.86	0.55	0.96	0.72	0.89	0.74	-0.9	0.66	0.89	0.76	0.77	0.83	0.84	-0.49	-0.46	0.11
Total Current Assets	0.52	0.49	0.05	0.73	0.54	0.59	0.64	0.54		0.59	0.07	0.7	0.58	0.46	0.59	0.17	-0.75	0.58	0.16	0.17	0.77	0.28	0.32	0.34	0.15	0.03
Short Term Debt	0.35	0.26	0.41	0.23	0.4	0.33	0.34	0.5	0.59		0.2	0.28	0.38	0.21	0.31	0.1	-0.43	0.36	0.18	0.08	0.42	0.36	0.29	-0.18	0.18	0.19
Intangible Assets	0.86	0.81	0.87	0.03	0.83	0.78	-0.62	0.86	0.07	0.2		0.23	0.8	0.6	0.73	0.84	-0.65	0.43	0.97	0.83	0.51	0.86	0.87	-0.75	-0.59	0.06
Common Stock	0.5	0.45	0.3	0.38	0.55	0.6	0.31	0.55	0.7	0.28	0.23		0.57	0.8	0.51	0.29	-0.62	0.28	0.26	0.41	0.52	0.21	0.27	-0.05	0.04	0.11
Current Deferred Revenue	0.93	0.87	0.69	0.39	0.96	0.99	-0.12	0.96	0.58	0.38	0.8	0.57		0.68	0.94	0.69	-0.94	0.73	0.87	0.72	0.82	0.79	0.78	-0.36	-0.54	0.12
Long Term Debt	0.73	0.71	0.56	0.35	0.75	0.69	-0.16	0.72	0.46	0.21	0.6	0.8	0.68		0.67	0.69	-0.65	0.18	0.55	0.83	0.57	0.41	0.62	-0.42	-0.02	-0.06
Property Plant Equipment	0.94	0.93	0.61	0.58	0.95	0.91	-0.05	0.89	0.59	0.31	0.73	0.51	0.94	0.67		0.78	-0.91	0.59	0.79	0.73	0.86	0.75	0.84	-0.26	-0.42	-0.13
Good Will	0.88	0.92	0.7	0.44	0.83	0.65	-0.44	0.74	0.17	0.1	0.84	0.29	0.69	0.69	0.78		-0.65	0.12	0.76	0.8	0.51	0.68	0.95	-0.52	-0.24	-0.43
Treasury Stock	-0.91	-0.88	-0.49	-0.62	-0.92	-0.91	-0.06	-0.9	-0.75	-0.43	-0.65	-0.62	-0.94	-0.65	-0.91	-0.65		-0.73	-0.72	-0.6	-0.89	-0.67	-0.77	0.14	0.31	-0.01
Net Tangible Assets	0.54	0.45	0.26	0.17	0.55	0.74	0.08	0.66	0.58	0.36	0.43	0.28	0.73	0.18	0.59	0.12	-0.73		0.6	0.29	0.73	0.61	0.36	0.0	-0.57	0.53
Capital Surpluse	0.86	0.81	0.82	0.05	0.84	0.85	-0.53	0.89	0.16	0.18	0.97	0.26	0.87	0.55	0.79	0.76	-0.72	0.6		0.79	0.6	0.9	0.83	-0.64	-0.71	0.17
Long Term Debt Total	0.78	0.76	0.68	0.17	0.77	0.72	-0.53	0.76	0.17	0.08	0.83	0.41	0.72	0.83	0.73	0.8	-0.6	0.29	0.79		0.6	0.63	0.75	-0.64	-0.31	0.05
Long Term Investments	0.79	0.77	0.33	0.62	0.79	0.8	0.16	0.77	0.77	0.42	0.51	0.52	0.82	0.57	0.86	0.51	-0.89	0.73	0.6	0.6		0.62	0.65	-0.07	-0.2	0.1
Short Long Term Debt	0.81	0.77	0.8	0.12	0.77	0.79	-0.26	0.83	0.28	0.36	0.86	0.21	0.79	0.41	0.75	0.68	-0.67	0.61	0.9	0.63	0.62		0.82	-0.49	-0.62	0.13
Net Invested Capital	0.95	0.96	0.71	0.48	0.89	0.75	-0.34	0.84	0.32	0.29	0.87	0.27	0.78	0.62	0.84	0.95	-0.77	0.36	0.83	0.75	0.65	0.82		-0.45	-0.29	-0.31
Net Working Capital	-0.4	-0.33	-0.8	0.44	-0.43	-0.31	0.74	-0.49	0.34	-0.18	-0.75	-0.05	-0.36	-0.42	-0.26	-0.52	0.14	0.0	-0.64	-0.64	-0.07	-0.49	-0.45		0.34	-0.25
Capital Stock	-0.37	-0.31	-0.49	0.33	-0.38	-0.57	0.4	-0.46	0.15	0.18	-0.59	0.04	-0.54	-0.02	-0.42	-0.24	0.31	-0.57	-0.71	-0.31	-0.2	-0.62	-0.29	0.34		-0.33
Cash And Equivalents	-0.15	-0.28	0.09	-0.57	-0.09	0.15	-0.09	0.11	0.03	0.19	0.06	0.11	0.12	-0.06	-0.13	-0.43	-0.01	0.53	0.17	0.05	0.1	0.13	-0.31	-0.25	-0.33

Click cells to compare fundamentals

Illumina Debt To Equity Historical Pattern

Today, most investors in Illumina Stock are looking for potential investment opportunities by analyzing not only static indicators but also various Illumina's growth ratios. Consistent increases or drops in fundamental ratios usually indicate a possible pattern that can be successfully translated into profits. However, when comparing two companies, knowing each company's debt to equity growth rates may not be enough to decide which company is a better investment. That's why investors frequently use a static breakdown of Illumina debt to equity as a starting point in their analysis.

Illumina Debt To Equity

Timeline

High Debt to Equity ratio typically indicates that a firm has been borrowing aggressively to finance its growth and as a result may experience a burden of additional interest expense. This may reduce earnings or future growth. On the other hand a small D/E ratio may indicate that a company is not taking enough advantage from financial leverage. Debt to Equity ratio measures how the company is leveraging borrowing against the capital invested by the owners.

Competition

Predict Illumina

Debt To Equity Over Time

Illumina Total Stockholder Equity

Total Stockholder Equity

6.03 Billion

At this time, Illumina's Total Stockholder Equity is very stable compared to the past year.

According to the company disclosure, Illumina has a Debt To Equity of 0.381%. This is 99.29% lower than that of the Life Sciences Tools & Services sector and 99.51% lower than that of the Health Care industry. The debt to equity for all United States stocks is 99.22% higher than that of the company.

Illumina Debt To Equity Peer Comparison

Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Illumina's direct or indirect competition against its Debt To Equity to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Illumina could also be used in its relative valuation, which is a method of valuing Illumina by comparing valuation metrics of similar companies.

Illumina is currently under evaluation in debt to equity category among its peers.

Illumina ESG Sustainability

Some studies have found that companies with high sustainability scores are getting higher valuations than competitors with lower social-engagement activities. While most ESG disclosures are voluntary and do not directly affect the long term financial condition, Illumina's sustainability indicators can be used to identify proper investment strategies using environmental, social, and governance scores that are crucial to Illumina's managers, analysts, and investors.

Environmental

Governance

Social

Illumina Fundamentals

	Return On Equity	-0.4
	Return On Asset	0.0262
	Profit Margin	(0.36) %
	Operating Margin	0.24 %
	Current Valuation	24.54 B
	Shares Outstanding	158.6 M
	Shares Owned By Insiders	0.27 %
	Shares Owned By Institutions	95.17 %
	Number Of Shares Shorted	6.72 M
	Price To Earning	49.12 X
	Price To Book	10.73 X
	Price To Sales	5.16 X
	Revenue	4.5 B
	Gross Profit	3.15 B
	EBITDA	(1.07 B)
	Net Income	(1.16 B)
	Cash And Equivalents	2.01 B
	Cash Per Share	6.62 X
	Total Debt	2.26 B
	Debt To Equity	0.38 %
	Current Ratio	0.93 X
	Book Value Per Share	13.45 X
	Cash Flow From Operations	478 M
	Short Ratio	3.97 X
	Earnings Per Share	(9.97) X
	Price To Earnings To Growth	0.62 X
	Target Price	164.6
	Number Of Employees	10.59 K
	Beta	1.13
	Market Capitalization	22.67 B
	Total Asset	10.11 B
	Retained Earnings	(19 M)
	Working Capital	1.04 B
	Current Asset	2.1 B
	Current Liabilities	610.49 M
	Net Asset	10.11 B

About Illumina Fundamental Analysis

The Macroaxis Fundamental Analysis modules help investors analyze Illumina's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Illumina using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Illumina based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Please read more on our fundamental analysis page.

Pair Trading with Illumina

One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Illumina position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Illumina will appreciate offsetting losses from the drop in the long position's value.

Moving together with Illumina Stock

0.74

DRUG

Bright Minds Biosciences

Pair Corr

Moving against Illumina Stock

0.77	FDMT	4D Molecular Therapeutics	Pair Corr
0.65	MRK	Merck Company Fiscal Year End 6th of February 2025	Pair Corr
0.63	ICU	LMF Acquisition Oppo	Pair Corr
0.5	VALN	Valneva SE ADR	Pair Corr
0.48	VRAX	Virax Biolabs Group	Pair Corr

The ability to find closely correlated positions to Illumina could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Illumina when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Illumina - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Illumina to buy it.

The correlation of Illumina is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Illumina moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Illumina moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

Correlation analysis and pair trading evaluation for Illumina can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.

Pair Correlation Correlation Matching

When determining whether Illumina offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Illumina's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Illumina Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Illumina Stock:

How To Invest In Illumina

Details

Is Illumina Stock a good investment?

Details

What is Illumina's Net Worth?

Details

Largest Life Sciences Tools & Services Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out Illumina Piotroski F Score and Illumina Altman Z Score analysis.

To learn how to invest in Illumina Stock, please use our How to Invest in Illumina guide.

You can also try the Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.

Is Life Sciences Tools & Services space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Illumina. If investors know Illumina will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Illumina listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Quarterly Earnings Growth

(0.96)

Earnings Share

(9.97)

Revenue Per Share

27.654

Quarterly Revenue Growth

(0.04)

Return On Assets

0.0262

The market value of Illumina is measured differently than its book value, which is the value of Illumina that is recorded on the company's balance sheet. Investors also form their own opinion of Illumina's value that differs from its market value or its book value, called intrinsic value, which is Illumina's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Illumina's market value can be influenced by many factors that don't directly affect Illumina's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Illumina's value and its price as these two are different measures arrived at by different means. Investors typically determine if Illumina is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Illumina's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Illumina Stock Debt To Equity

Illumina Company Debt To Equity Analysis

D/E

Total Debt

Total Equity

Current Illumina Debt To Equity

Illumina Debt To Equity Driver Correlations

Illumina Debt To Equity Historical Pattern

Illumina Total Stockholder Equity

Total Stockholder Equity

6.03 Billion

Illumina Debt To Equity Peer Comparison

Illumina ESG Sustainability

Illumina Fundamentals

About Illumina Fundamental Analysis

Pair Trading with Illumina

Moving together with Illumina Stock

Moving against Illumina Stock

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY